331.23
price up icon1.02%   3.36
after-market After Hours: 331.23
loading
Madrigal Pharmaceuticals Inc stock is traded at $331.23, with a volume of 324.68K. It is up +1.02% in the last 24 hours and down -2.94% over the past month.
See More
Previous Close:
$327.87
Open:
$317.62
24h Volume:
324.68K
Relative Volume:
0.90
Market Cap:
$7.45B
Revenue:
-
Net Income/Loss:
$-518.67M
P/E Ratio:
-13.19
EPS:
-25.12
Net Cash Flow:
$-438.32M
1W Performance:
-4.38%
1M Performance:
-2.94%
6M Performance:
+56.08%
1Y Performance:
+24.04%
1-Day Range:
Value
$310.00
$333.00
1-Week Range:
Value
$310.00
$350.50
52-Week Range:
Value
$189.00
$377.46

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
Name
Madrigal Pharmaceuticals Inc
Name
Phone
404-380-9263
Name
Address
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
Employee
0
Name
Twitter
@MadrigalPharma
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
MDGL's Discussions on Twitter

Compare MDGL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MDGL
Madrigal Pharmaceuticals Inc
331.23 7.45B 0 -518.67M -438.32M -25.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-25 Upgrade B. Riley Securities Neutral → Buy
Feb-27-25 Reiterated H.C. Wainwright Buy
Jun-28-24 Initiated Cantor Fitzgerald Neutral
Jun-11-24 Initiated Wolfe Research Outperform
Apr-22-24 Initiated BofA Securities Underperform
Mar-15-24 Upgrade B. Riley Securities Sell → Neutral
Mar-06-24 Initiated Citigroup Buy
Feb-26-24 Downgrade B. Riley Securities Neutral → Sell
Dec-20-22 Reiterated Oppenheimer Outperform
Dec-19-22 Reiterated H.C. Wainwright Buy
Dec-19-22 Reiterated Piper Sandler Overweight
Dec-19-22 Upgrade Raymond James Underperform → Mkt Perform
Jul-08-22 Downgrade B. Riley Securities Buy → Neutral
Oct-07-21 Initiated Jefferies Buy
Aug-06-21 Upgrade BMO Capital Markets Market Perform → Outperform
May-20-21 Resumed Goldman Buy
Nov-24-20 Resumed Evercore ISI Outperform
Nov-06-20 Reiterated H.C. Wainwright Buy
Jul-31-20 Initiated Piper Sandler Overweight
Jun-05-20 Initiated BMO Capital Markets Market Perform
May-05-20 Initiated Chardan Capital Markets Buy
Jan-30-20 Initiated Canaccord Genuity Buy
Jan-09-20 Upgrade UBS Neutral → Buy
Nov-07-19 Reiterated H.C. Wainwright Buy
Jun-25-19 Initiated Stifel Hold
Jun-10-19 Upgrade B. Riley FBR Neutral → Buy
Feb-28-19 Reiterated H.C. Wainwright Buy
Feb-22-19 Initiated SVB Leerink Outperform
Jan-23-19 Initiated UBS Neutral
Dec-14-18 Initiated Wolfe Research Outperform
Dec-12-18 Initiated B. Riley FBR Neutral
Nov-19-18 Downgrade Raymond James Mkt Perform → Underperform
Nov-16-18 Upgrade Evercore ISI In-line → Outperform
Sep-04-18 Initiated Citigroup Buy
Aug-06-18 Downgrade Goldman Buy → Neutral
Jun-28-18 Initiated Raymond James Mkt Perform
View All

Madrigal Pharmaceuticals Inc Stock (MDGL) Latest News

pulisher
Mar 28, 2025

Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Madrigal (MDGL) Up 0.5% Since Last Earnings Report: Can It Continue? - Nasdaq

Mar 28, 2025
pulisher
Mar 25, 2025

Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long - simplywall.st

Mar 25, 2025
pulisher
Mar 21, 2025

(MDGL) On The My Stocks Page - Stock Traders Daily

Mar 21, 2025
pulisher
Mar 20, 2025

EU health regulator clears use of AI tool in fatty liver disease trials - Reuters

Mar 20, 2025
pulisher
Mar 18, 2025

Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 18, 2025
pulisher
Mar 15, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 15, 2025
pulisher
Mar 15, 2025

Madrigal Pharmaceuticals Announces Changes to Board of Directors - MSN

Mar 15, 2025
pulisher
Mar 14, 2025

Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential - Investing.com India

Mar 13, 2025
pulisher
Mar 12, 2025

Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Victory Capital Management Inc. Has $21.80 Million Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Bank of New York Mellon Corp Lowers Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Madrigal Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

How the (MDGL) price action is used to our Advantage - Stock Traders Daily

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Pharmaceuticals Expands Board with New Appointment - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal appoints Jacqualyn Fouse to its board -March 11, 2025 at 09:36 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Appoints Jacqualyn A. Fouse, Ph.D. To Board - citybiz

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Pharmaceuticals appoints new board member - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Why Madrigal Pharmaceuticals (MDGL) Stock is Rising Today - GuruFocus.com

Mar 11, 2025
pulisher
Mar 10, 2025

Robert E. Waltermire Sells 14,113 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, - GuruFocus.com

Mar 09, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals Exec Cashes Out in Multi-Million Dollar Stock Sale! - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Holdings Reduced by Principal Financial Group Inc. - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Madrigal Pharmaceuticals CFO Mardi sells $637,247 in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Madrigal Pharmaceuticals exec sells $418,488 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 04, 2025

Madrigal Pharmaceuticals exec sells $418,488 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 6.8% on Insider Selling - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

B. Riley Analysts Increase Earnings Estimates for MDGL - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Sanctuary Advisors LLC Acquires 62 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

HC Wainwright Issues Negative Estimate for MDGL Earnings - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch - MSN

Mar 02, 2025
pulisher
Mar 01, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives $351.67 Consensus PT from Analysts - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

New York State Common Retirement Fund Sells 5,630 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Citigroup Boosts Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $469.00 - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock By Investing.com - Investing.com Australia

Feb 28, 2025
pulisher
Feb 28, 2025

(MDGL) Trading Report - Stock Traders Daily

Feb 28, 2025
pulisher
Feb 28, 2025

Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock - Investing.com

Feb 28, 2025

Madrigal Pharmaceuticals Inc Stock (MDGL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):